Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | ERN1 | O75460 | 1/20 | 0.56 |
| ▸ | MKNK1 | Q9BUB5 | 4/20 | 0.55 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | TTK | P33981 | 1/20 | 0.53 |
| ▸ | KIF11 | P52732 | 1/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.52 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30088429 | 1.00 | CYP2A6 (0.60) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 | |
| Trifluoroacetic Acid SCHEMBL7012854 | 0.86 | MKNK1 (0.54) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 | |
| SCHEMBL24534338 | 0.82 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2MKNK1 | |
| SCHEMBL13907273 | 0.82 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2MKNK1 | |
| SCHEMBL29360677 | 0.82 | CYP2A6 (0.88) | CYP2A6CYP3A4ALDH1A1CYP1A2MKNK1 | |
| SCHEMBL6753899 | 0.82 | CYP2A6 (0.52) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 | |
| SCHEMBL6753897 | 0.82 | CYP2A6 (0.52) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 | |
| SCHEMBL844773 | 0.81 | CYP2A6 (0.56) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 | |
| SCHEMBL29569162 | 0.81 | ERN1 (0.57) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 | |
| SCHEMBL958907 | 0.81 | ERN1 (0.57) | CYP2A6CYP3A4ALDH1A1CYP1A2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116622087-A | MOFs material constructed by acid-base mixed ligand and preparation method thereof | 嘉兴学院 | 2023-08-22 | — | — | CN | claimed |
| CN-100343256-C | Biaryl substituted diazabicycloalkane amides as nicotinic acetylcholine agonists | ASTRAZENECA AB (SE) | 2007-10-17 | — | — | CN | claimed |
| CN-1678615-A | Biaryl substituted diazabicycloalkanes as nicotinic acetylcholine antagonists | ASTRAZENECA AB (SE) | 2005-10-05 | — | — | CN | claimed |
| US-20260078104-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2026-03-19 | — | — | US | disclosed |
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| US-12545656-B2 | Organic light-emitting compound and organic electroluminescent device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2026-02-10 | — | — | US | disclosed |
| US-20240368147-A1 | CYCLIN K DEGRADER | ADLAI NORTYE BIOPHARMA CO., LTD. (CN) | 2024-11-07 | — | — | US | disclosed |
| EP-4382519-A1 | CYCLIN K DEGRADATION AGENT | Adlai Nortye Biopharma Co., Ltd. (CN) | 2024-06-12 | — | — | EP | disclosed |
| US-11980613-B2 | Methods for reversing HIV latency using BAF complex modulating compounds | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-05-14 | — | — | US | disclosed |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | LG CHEM, LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| WO-1997040029-A1 | ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES | NOVARTIS AG (CH) | 1997-10-30 | — | — | WO | disclosed |
| US-5607953-A | ANTIISCHEMIC AGENTS | EISAI CO., LTD. (JP) | 1997-03-04 | — | — | US | disclosed |
| EP-0344577-B1 | Butenoic or propenoic acid derivatives | EISAI CO LTD (JP) | 1996-10-09 | — | — | EP | disclosed |
| EP-0656897-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1995-06-14 | — | — | EP | disclosed |
| US-5382595-A | Antiischemic agents | EISAI CO., LTD. (JP) | 1995-01-17 | — | — | US | disclosed |
| WO-1994005660-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1994-03-17 | — | — | WO | disclosed |
| US-5177089-A | Antiischemic agent, vasodilator | EISAI CO., LTD. (JP) | 1993-01-05 | — | — | US | disclosed |
| CN-1040366-A | Butenoic acid or acrylic acid derivative | EISAI CO LTD (JP) | 1990-03-14 | — | — | CN | disclosed |
| EP-0344577-A2 | Butenoic or propenoic acid derivatives | Eisai Co., Ltd. (JP) | 1989-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | CYP2A6 268/4885CYP3A4 1033/4885ALDH1A1 290/4885 |
| US-12570675-B2 | Boronic acid compounds | PSMB6, PSMB3, PSMB2 | CYP2A6 125/4885CYP3A4 1946/4885ALDH1A1 3621/4885 |
| US-20240368147-A1 | CYCLIN K DEGRADER | CCNK, CCNI, CDK1 | CYP2A6 1473/4885CYP3A4 2671/4885ALDH1A1 3968/4885 |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | PSMB11, PSMB1, BACH1 | CYP2A6 805/4885CYP3A4 3383/4885ALDH1A1 2005/4885 |
| US-12545656-B2 | Organic light-emitting compound and organic electroluminescent device using the same | ELOVL1, EPB41L2, L1CAM | CYP2A6 1687/4885CYP3A4 349/4885ALDH1A1 268/4885 |
| US-11980613-B2 | Methods for reversing HIV latency using BAF complex modulating compounds | CHD1L, SMARCC1, CHD1 | CYP2A6 3991/4885CYP3A4 4332/4885ALDH1A1 4091/4885 |
| US-20260078104-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | ELOC, ELOVL1, EMC1 | CYP2A6 2008/4885CYP3A4 1608/4885ALDH1A1 1368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.